23andMe (NASDAQ:ME) Announces Earnings Results

23andMe (NASDAQ:ME) released its earnings results on Tuesday. The company reported ($1.02) earnings per share for the quarter, Zacks reports. 23andMe had a negative return on equity of 129.98% and a negative net margin of 318.39%.

23andMe Trading Up 1.5 %

NASDAQ ME traded up $0.05 during trading on Tuesday, reaching $3.40. The company’s stock had a trading volume of 138,534 shares, compared to its average volume of 192,537. The stock has a market capitalization of $88.81 million, a PE ratio of -0.13 and a beta of 1.14. 23andMe has a 1-year low of $2.65 and a 1-year high of $16.52. The business has a 50-day moving average price of $3.46 and a 200-day moving average price of $5.41.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of 23andMe in a research note on Saturday, January 18th.

23andMe Company Profile

23andMe Holding Co operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications.